KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Goodwill & Intangibles (2016 - 2025)

Jazz Pharmaceuticals has reported Goodwill & Intangibles over the past 16 years, most recently at $6.3 billion for Q4 2025.

  • Quarterly results put Goodwill & Intangibles at $6.3 billion for Q4 2025, down 3.29% from a year ago — trailing twelve months through Dec 2025 was $6.3 billion (down 3.29% YoY), and the annual figure for FY2025 was $6.3 billion, down 3.29%.
  • Goodwill & Intangibles for Q4 2025 was $6.3 billion at Jazz Pharmaceuticals, down from $6.4 billion in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for JAZZ hit a ceiling of $9.5 billion in Q2 2021 and a floor of $1.9 billion in Q3 2021.
  • Median Goodwill & Intangibles over the past 5 years was $7.0 billion (2024), compared with a mean of $6.6 billion.
  • Biggest five-year swings in Goodwill & Intangibles: skyrocketed 830.8% in 2021 and later tumbled 66.53% in 2023.
  • Jazz Pharmaceuticals' Goodwill & Intangibles stood at $9.0 billion in 2021, then dropped by 16.62% to $7.5 billion in 2022, then tumbled by 66.53% to $2.5 billion in 2023, then soared by 158.3% to $6.5 billion in 2024, then decreased by 3.29% to $6.3 billion in 2025.
  • The last three reported values for Goodwill & Intangibles were $6.3 billion (Q4 2025), $6.4 billion (Q3 2025), and $6.6 billion (Q2 2025) per Business Quant data.